Inactive Instrument

Press Releases Algeta ASA Xetra

Equities

GJ9

NO0010239437

End-of-day quote Xetra Other stock markets
- ^EUR	-

2014	Actavis : Factbox - M&A frenzy transforming global pharma	RE
2014	Actavis : M&A frenzy in healthcare sector	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Algeta ASA : Algeta to host Capital Markets Days	13-11-18	PU
Algeta ASA : CORRECTION: Algeta ASA : Algeta Results for the Third Quarter 2013	13-11-08	PU
Algeta ASA : Algeta's Financial Calendar 2014	13-11-08	PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences	13-11-05	PU
Algeta ASA : Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call	13-10-28	PU
Algeta ASA : New data and analyses from the phase III ALSYMPCA trial of radium Ra 223 dichloride to be presented at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013	13-09-12	PU
Algeta ASA : Algeta results for the First Half and Second Quarter 2013	13-08-28	PU
Algeta ASA : Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer	13-08-19	PU
Algeta ASA : Algeta schedules first half and second quarter 2013 results presentation, webcast and conference call	13-08-19	PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences	13-08-12	PU
Algeta ASA : Algeta celebrates the official opening of its commercial production facility for Xofigo® (radium Ra 223 dichloride) at the Institute for Energy Technology (IFE) in Norway	13-06-20	PU
Algeta ASA : Algeta to evaluate novel Targeted Thorium Conjugate (TTC) based on Avipep's Avibody platform	13-06-11	PU
Algeta ASA : Algeta announces first sale of Xofigo® (radium Ra 223 dichloride) in the United States	13-05-30	PU
Algeta ASA : New data and analyses from clinical trials of Xofigo® (radium-223 dichloride) to be presented at ASCO	13-05-16	PU
Algeta ASA : Algeta announces that Xofigo® (radium-223 dichloride) has been approved by the US FDA	13-05-15	PU
Algeta ASA : Algeta results for the first quarter 2013	13-05-15	PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences	13-05-14	PU
Algeta ASA : Algeta schedules first quarter 2013 results presentation, webcast and conference call	13-05-07	PU
Algeta ASA : Algeta exercises option and signs exclusive license agreement with Lumiphore, Inc. for novel technology for development of Targeted Thorium Conjugates (TTCs)	13-05-02	PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conference	13-04-17	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Algeta ASA Xetra

Equities

GJ9

NO0010239437

Press Releases

Filters